I2020
Business Services · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
47 Thorndike St Ste B1-1, Cambridge, Mas...Phone Number
(858) 724-0581Website
www.i2020accelerator.comRevenue
<$5 MillionIndustry
About I2020
Is I2020 your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if I2020 is spiking on competitors!
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on I2020 recently announced quarterly report
Click to see if I2020 had a recent Job posting/layoffs
I2020, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at I2020
Check if I2020 has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when I2020 launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once I2020 has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to I2020
Compare insights from companies similar to I2020, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
I2020
Company Profile Activity
Activity Insights
I2020 is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
I2020 is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about I2020.
I2020 Tech Stack
A closer look at the technologies used by I2020
Top Business Services Companies
Frequently Asked Questions Regarding I2020
i2020 Accelerator, operated by T123 LLC, specializes in accelerating early-stage drug discovery by de-risking novel science and enhancing partner pipelines with high-quality molecules. The company collaborates with a global network to support diverse therapeutic areas, including immunology and infectious diseases, aiming to co-create 20-30 drug dis... Read More